Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Moving Toward Virtual Networks: Spotlight On Pfizer R&D

This article was originally published in PharmAsia News

Executive Summary

PERTH, Australia - Pfizer's Asia strategy will focus on building a virtual network of collaborations with leading contract research organizations and academic groups rather than building bricks-and-mortar R&D facilities

You may also be interested in...



Aussie Drug Delivery Company PolyActiva Raises AU$9.2 Mil In Series B For Glaucoma Candidate

With AU$9.2 million in Series B financing, Australian drug delivery company prepares Phase II trial for levofloxacin antibiotic delivery system.

Pfizer Avoids Japan R&D Layoffs With Creation Of New Business

Pfizer is spinning off some of its Nagoya, Japan, research site into a venture-backed start-up called RaQualia Pharma Inc., the company reported July 3

Big Pharma Stretches To Reshape Itself To Enter Asia With Flexible, Multiple-Partner Networks – Singapore Conference

SINGAPORE - As big pharma looks across Asia for new ways of doing business, execs from the top pharma companies agreed that having people on the ground in Asia is critical and that companies are moving away from being fully integrated pharma companies to becoming fully integrated pharma networks

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC069220

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel